XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:        
Net loss $ (7,354,742) $ (725,479) $ 4,103,067 $ (501,295)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization of debt discount 1,870,474 84,625 94,168 87,289
Shares issued for services 544,233 6,125 6,125
Change in fair value of warrant liability 667,630 397,553
Change in fair value of earnout shares liability (1,052,494) (18,731,514)
Default penalties and interest on notes payable 1,276,447    
Loss on extinguishment of debt 598,324    
Stock issued for forbearance fee     13,226,926
Change in assets and liabilities:        
Prepaid expenses 654,701 (801,386)
Other receivables     17,224 (15,000)
Employee advance (7,500) 15,000    
Accounts payable and accrued expenses 705,963 48,862 41,893 11,844
Accrued expenses - related party (14,226) (88,350) (120,083)
Accrued interest payable - related party 41,291 43,267 57,795 22,064
Net cash used in operating activities (2,055,673) (541,826) (1,676,499) (515,181)
Cash flows from investing activities:        
Cash acquired with merger     2,537
Acquisition cots     (361,643)
Purchase of property, plant and equipment (8,050)    
Net cash provided by investing activities (8,050) (359,106)
Cash flows from financing activities:        
Proceeds from notes payable to related party 2,800,000 500,000 500,000 821,941
Repayment of notes payable to related party (800,000) (23,972) (123,972) (61,957)
Repayment of due to investor     (1,000,000)
Proceeds from convertible notes payable 500,000 2,600,000
Repayment of convertible notes payable (500,000)    
Proceeds from financing payable     663,582
Repayment of financing payable (596,386)    
Repurchase of common stock to cancel     (141,000)
Proceeds from sale of common stock 25,000 25,000
Net cash provided by financing activities 1,403,614 501,028 2,664,610 618,984
Net change in cash (660,109) (40,798) 629,005 103,803
Cash at beginning of period 735,814 106,809 106,809 3,006
Cash at end of period 75,705 66,011 735,814 106,809
Supplemental disclosures of cash flow information:        
Cash paid for interest
Cash paid for taxes 200
Supplemental non-cash information        
Net assets and liabilities assumed in the merger     (25,236,215)
Conversion of preferred series A stock into common stock     510
Conversion of preferred series B stock into common stock     10,000
Common shares cancelled per forfeiture agreement     85
Common shares cancelled for reimbursement of expenses     208,433
Common shares issued for note extension with related party     35,000
Renegotiated notes payable 453,750 487,500
Discounts on notes payable applied directly against accumulated deficit 14,087 $ 14,087 $ 44,077
Common shares issued as financing incentive 1,437,375    
Common shares issued from conversion of preferred series C shares 30,638,517    
Common shares issued from conversion of convertible notes payable 3,750,000    
Shares issued to related party applied directly against accumulated deficit $ 35,000